Annual report pursuant to Section 13 and 15(d)

Segment Reporting - Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, Interest Expense and Assets by Segment (Detail)

v3.20.4
Segment Reporting - Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, Interest Expense and Assets by Segment (Detail) - USD ($)
 12 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Segment Reporting Information [Line Items]    
Total net revenue $ 31,147,593 $ 31,816,571
Total cost of sales 9,657,442 10,036,175
Total operating profit 7,661,597 5,062,706
Total depreciation and amortization 166,437 206,238
Total interest expense 1,544,017 1,703,446
Total assets 46,200,094 42,886,160
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member]    
Segment Reporting Information [Line Items]    
Total assets 34,215,780 28,975,002
PrepaCyte CB [Member]    
Segment Reporting Information [Line Items]    
Total assets 302,683 289,804
Public Cord Blood Banking [Member]    
Segment Reporting Information [Line Items]    
Total assets 11,681,631 13,621,354
Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 372,289 401,311
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member]    
Segment Reporting Information [Line Items]    
Total net revenue 30,176,852 30,991,972
Total cost of sales 7,731,227 8,490,824
Total operating profit 9,928,886 8,152,475
Total interest expense 1,544,017 1,703,446
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member] | Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 344,711 365,057
PrepaCyte CB [Member]    
Segment Reporting Information [Line Items]    
Total net revenue 244,187 172,395
Total cost of sales 156,111 249,487
Total operating profit 60,499 (113,346)
PrepaCyte CB [Member] | Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 27,578 36,254
Public Cord Blood Banking [Member]    
Segment Reporting Information [Line Items]    
Total net revenue 726,554 652,204
Total cost of sales 1,770,104 1,295,864
Total operating profit $ (2,327,788) $ (2,976,423)